Industryweek 2648 Ge Healthcare Logo 1
Industryweek 2648 Ge Healthcare Logo 1
Industryweek 2648 Ge Healthcare Logo 1
Industryweek 2648 Ge Healthcare Logo 1
Industryweek 2648 Ge Healthcare Logo 1

GE Healthcare, iBio Join to Use Plant-based Technologies to Manufacture Biopharmaceuticals

July 27, 2012
Companies also working together to develop a a single, flexible facility which could significantly reduce operating costs.

Using iBio's plant-based vaccine manufacturing platform and GE Healthcare's technological experience in biopharmaceutical manufacturing, the two companies on Thursday announced they will commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

The iBioLaunch platform is a gene expression technology that induces plants to rapidly produce high levels of proteins such as vaccines, in a process which can be scaled-up in low cost, controlled-growth facilities.

GE Healthcare’s global team of bioengineers and bioprocessing scientists are working with researchers from iBio and the Fraunhofer USA Center for Molecular Biotechnology to develop a single, flexible facility which could significantly reduce the capital and operating costs of biotherapeutic and vaccine manufacture compared with traditional animal cell and microbial based methods. The iBioLaunch platform also has the potential to manufacture proteins which cannot be commercially produced in any other system.

iBio's pioneering plant-based technology has been used to produce an avian influenza vaccine candidate that recently completed a successful Phase I clinical trial. The work was funded by the Bill & Melinda Gates Foundation. The iBioLaunch platform was also used to produce a candidate vaccine against H1N1 influenza, for which a human Phase I trial was successfully completed in March, 2012.

"We look forward to working together on the development of a flexible and cost-effective plant-based manufacturing platform that has the potential to assist in the global effort to increase access to biotherapeutics and help reduce the incidence of vaccine preventable diseases," Robert B. Kay, CEO of iBio Inc.

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!